Back
Vertex Pharmaceuticals Stock Price Chart

Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
48
VRTX
Vertex Pharmaceuticals
Last Price:
$484.14
Seasonality Move:
12.78%
7 Day Trial
ALL ACCESS PASS
$
7

Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is moderately bearish and VRTX is experiencing slight selling pressure.
Vertex Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 496.17 | Sell |
20-day SMA: | 498.92 | Sell |
50-day SMA: | 476.7 | Buy |
200-day SMA: | 470.1 | Buy |
8-day EMA: | 492.65 | Sell |
20-day EMA: | 493.67 | Sell |
50-day EMA: | 480.53 | Buy |
200-day EMA: | 459.75 | Buy |
Vertex Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.57 | Buy |
Relative Strength Index (14 RSI): | 44 | Sell |
Chaikin Money Flow: | -178991 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (483.21 - 507.29) | Sell |
Bollinger Bands (100): | (429.88 - 495.3) | Buy |
Vertex Pharmaceuticals Technical Analysis
Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Vertex Pharmaceuticals Stock
Is Vertex Pharmaceuticals Stock a Buy?
-
Vertex Pharmaceuticals share price is 483.49 while VRTX 8-day simple moving average is 496.17, which is a Sell signal.
-
The stock price of VRTX is 483.49 while Vertex Pharmaceuticals 20-day SMA is 498.92, which makes it a Sell.
-
Vertex Pharmaceuticals 50-day simple moving average is 476.70 while VRTX share price is 483.49, making it a Buy technically.
-
VRTX stock price is 483.49 and Vertex Pharmaceuticals 200-day simple moving average is 470.10, creating a Buy signal.
VRTX Technical Analysis vs Fundamental Analysis
Sell
48
Vertex Pharmaceuticals (VRTX)
is a Sell
Is Vertex Pharmaceuticals a Buy or a Sell?
-
Vertex Pharmaceuticals stock is rated a SellThe current Vertex Pharmaceuticals [VRTX] share price is $483.49. The Score for VRTX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
Vertex Pharmaceuticals Stock Info
Market Cap:
124.2B
Price in USD:
483.49
Share Volume:
988.4K
Vertex Pharmaceuticals 52-Week Range
52-Week High:
519.88
52-Week Low:
377.85
Sell
48
Vertex Pharmaceuticals (VRTX)
is a Sell
Vertex Pharmaceuticals Share Price Forecast
-
What is the Vertex Pharmaceuticals stock price today?The Vertex Pharmaceuticals stock price is 483.49 USD today.
-
Will VRTX stock go up or go down?Vertex Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Vertex Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Vertex Pharmaceuticals is overvalued.
Is Vertex Pharmaceuticals Stock a Buy?
-
Vertex Pharmaceuticals share price is 483.49 while VRTX 8-day exponential moving average is 492.65, which is a Sell signal.
-
The stock price of VRTX is 483.49 while Vertex Pharmaceuticals 20-day EMA is 493.67, which makes it a Sell.
-
Vertex Pharmaceuticals 50-day exponential moving average is 480.53 while VRTX share price is 483.49, making it a Buy technically.
-
VRTX stock price is 483.49 and Vertex Pharmaceuticals 200-day simple moving average is 459.75, creating a Buy signal.
Fundamental Analysis of Vertex Pharmaceuticals
Is Vertex Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.44 per share, an increase next quarter of $0.16 per share, an increase this year of $17.56 per share, and an increase next year of $2.41 per share.
Technical Analysis of Vertex Pharmaceuticals
Should I short Vertex Pharmaceuticals stock?
-
VRTX Moving Average Covergence Divergence (MACD) indicator is 3.57, suggesting Vertex Pharmaceuticals is a Buy
-
Vertex Pharmaceuticals Relative Strength Index (RSI) is 44, which suggest Vertex Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Vertex Pharmaceuticals is (483.21 - 507.29), which suggest Vertex Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Vertex Pharmaceuticals is (429.88 - 495.3), which suggest Vertex Pharmaceuticals is a Buy
* Vertex Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.